Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p8
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 8/22)
Character Range: 203829–207496

DUPILUMAB.
DURVALUMAB.
DUTASTERIDE.
DYDROGESTERONE.
ECONAZOLE except:
 (a) when included in Schedule 2, 3 or 6; or
 (b) in preparations for dermal use for the treatment of tinea pedis.
ECOTHIOPATE (includes ecothiopate iodide).
ECTYLUREA.
ECULIZUMAB.
EDARAVONE.
EDETIC ACID for human therapeutic use except:
 (a) in preparations containing 0.25% or less of edetic acid; or
 (b) as dicobalt edetate in preparations for the treatment of cyanide poisoning; or
 (c) in contact lens preparations.
EDOXUDINE.
EDROPHONIUM.
EFALIZUMAB.
EFAVIRENZ.
EFGARTIGIMOD ALFA.
EFLORNITHINE.
ELACESTRANT DIHYDROCHLORIDE.
ELBASVIR.
ELETRIPTAN except when included in Schedule 3.
ELEXACAFTOR.
ELOSULFASE ALFA.
ELOTUZUMAB.
ELRANATAMAB.
ELTENAC.
ELTROMBOPAG.
ELUXADOLINE.
ELVITEGRAVIR.
EMEPRONIUM.
EMETINE except in preparations containing 0.2% or less of emetine.
EMPAGLIFLOZIN.
EMTRICITABINE.
ENALAPRIL.
ENASIDENIB.
ENCORAFENIB.
# ENESTEBOL.
ENFLURANE for therapeutic use.
ENFORTUMAB VEDOTIN.
ENFUVIRTIDE.
# ENOBOSARM.
ENOXACIN.
ENOXAPARIN.
ENOXIMONE.
ENPROSTIL.
ENROFLOXACIN.
ENTACAPONE.
ENTECAVIR.
ENTRECTINIB.
ENZALUTAMIDE.
EPHEDRA spp. except in preparations containing 0.001% or less of ephedrine.
# EPHEDRINE.
EPICILLIN.
EPINASTINE.
EPIRUBICIN.
# EPITIOSTANOL.
EPLERENONE.
# EPOETINS.
EPOPROSTENOL.
EPROSARTAN.
EPTIFIBATIDE.
ERENUMAB.
ERGOMETRINE.
ERGOT.
ERGOTAMINE.
ERGOTOXINE.
ERIBULIN MESILATE.
ERLOTINIB.
ERTAPENEM.
ERTUGLIFLOZIN.
ERYSIMUM spp.
ERYTHROMYCIN.
# ERYTHROPOIETIN.
# ERYTHROPOIETINS except when separately specified in these Schedules.
ESCITALOPRAM.
ESLICARBAZEPINE ACETATE.
ESMOLOL.
ESOMEPRAZOLE except when included in Schedule 2.
ESTETROL MONOHYDRATE.
ESTRADIOL except when included in Schedule 5.
ESTRIOL.
ESTRAMUSTINE.
ESTROGENS except when separately specified in these Schedules.
ESTRONE.
ESTROPIPATE (piperazine estrone sulfate).
ETACRYNIC ACID.
ETANERCEPT.
ETHAMBUTOL.
ETHAMIVAN.
ETHCHLORVYNOL.
ETHER for use in anaesthesia.
ETHINAMATE.
ETHINYLESTRADIOL.
ETHIONAMIDE.
# ETHISTERONE.
ETHOGLUCID.
ETHOHEPTAZINE.
ETHOPROPAZINE.
ETHOSUXIMIDE.
ETHOTOIN.
ETHOXZOLAMIDE.
ETHYL CHLORIDE for human therapeutic use.
# ETHYLDIENOLONE.
ETHYLMORPHINE when compounded with one or more other therapeutically active substances:
 (a) in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or
 (b) in undivided preparations with a concentration of not more than 2.5% of ethylmorphine.
# ETHYLESTRENOL.
ETIDOCAINE.
ETIDRONIC ACID (includes etidronate disodium):
 (a) for internal use; or
 (b) in topical preparations except in preparations containing 1% or less of etidronic acid.
ETILEFRIN.
ETIPROSTON.
ETODOLAC.
ETOFENAMATE except when included in Schedule 2.
ETONOGESTREL.
ETOPOSIDE.
ETORICOXIB.
ETRANACOGENE DEZAPARVOVEC.
ETRASIMOD.
ETRAVIRINE.
# ETRETINATE.
ETYNODIOL.
EVEROLIMUS.
EXEMESTANE.
EXENATIDE.
EZETIMIBE.
FAMCICLOVIR except when included in Schedule 3.
FAMOTIDINE except when included in Schedule 2.
FARICIMAB.
FASORACETAM.
FEBUXOSTAT.
FEDRATINIB.
FELBINAC except when included in Schedule 2.
FELODIPINE.
FELYPRESSIN.
FENBUFEN.
FENCAMFAMIN.
FENCLOFENAC.
FENFLURAMINE.
FENOFIBRATE.
FENOLDOPAM.
FENOPROFEN.
FENOTEROL.
FENPIPRAMIDE.
FENPIPRANE.
FENPROPOREX.
FENPROSTALENE.
FERRIC DERISOMALTOSE.
FEXOFENADINE except:
 (a) when included in Schedule 2; or
 (b) in divided preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

          (i) in a primary pack containing 20 dosage units or less and not more than 10 days' supply; and

          (ii) labelled with a recommended daily dose not exceeding 120 mg of fexofenadine; or
 (c) for the treatment of seasonal allergic